Home / Bevacizumab / Italy
IT ATC L01FG01 · updated 2 Nov 2026
Bevacizumab shortage in Italy
Is there a Bevacizumab shortage in Italy?
Yes. As of 2 Nov 2026, 3 Bevacizumab products are reported short in Italy, the first since 8 Feb 2026. No return date has been given. Main reason: increased demand.
Not reported short in any other country we track. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | AYBINTIO | SAMSUNG BIOEPIS NL B.V. | 8 Feb 2026 | not given | Increased demand Elevata richiesta |
| IT | AYBINTIO | SAMSUNG BIOEPIS NL B.V. | 21 Feb 2026 | not given | Increased demand Elevata richiesta |
| IT | VEGZELMA | CELLTRION HEALTHCARE HUNGARY KFT | 1 May 2026 | not given | Increased demand Elevata richiesta |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.